Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 29.3B | 32.2B | 30.3B | 31.4B |
Cost of revenue | 16.9B | 19.2B | 18.1B | 18.4B |
Gross profit | 12.4B | 13.0B | 12.2B | 13.0B |
Operating expense | ||||
Research & development | 1.2B | 1.2B | 1.0B | 1.2B |
Selling general and admin | 6.1B | 6.0B | 5.7B | 6.1B |
Other operating expenses | -15M | 18M | 540M | 191M |
Operating income | 5.2B | 5.7B | 4.9B | 5.6B |
Non operating interest income | ||||
Income | 204M | 352M | 160M | 140M |
Expense | 501M | 716M | 685M | 703M |
Other income expense | — | — | — | — |
Pretax income | 4.9B | 5.4B | 4.4B | 5.0B |
Tax provision | 1.2B | 1.1B | 1.2B | 1.5B |
Net income | 3.7B | 4.3B | 3.2B | 3.5B |
Basic EPS | 3.0 | 3.4 | 2.6 | 2.8 |
Diluted EPS | 3.0 | 3.4 | 2.6 | 2.8 |
Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
Diluted average shares | 1.3B | 1.3B | 1.3B | 1.3B |
EBITDA | 7.3B | 8.1B | 7.0B | 7.6B |
Net income from continuing op. | 4.9B | 5.4B | 4.4B | 5.0B |
Minority interests | 0 | 0 | -2M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |